#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0008] DNA micro-arrays adapted to utilize a hybridization reaction are expected to find applications in the field of medical diagnosis for identifying specific pathogenic microbes and gene diagnosis for examining bodily constitutions of patients.
1-1	0-1	[	_	_	
1-2	1-5	0008	_	_	
1-3	5-6	]	_	_	
1-4	7-10	DNA	_	_	
1-5	11-23	micro-arrays	_	_	
1-6	24-31	adapted	_	_	
1-7	32-34	to	_	_	
1-8	35-42	utilize	_	_	
1-9	43-44	a	_	_	
1-10	45-58	hybridization	_	_	
1-11	59-67	reaction	_	_	
1-12	68-71	are	_	_	
1-13	72-80	expected	_	_	
1-14	81-83	to	_	_	
1-15	84-88	find	_	_	
1-16	89-101	applications	_	_	
1-17	102-104	in	_	_	
1-18	105-108	the	_	_	
1-19	109-114	field	_	_	
1-20	115-117	of	_	_	
1-21	118-125	medical	_	_	
1-22	126-135	diagnosis	_	_	
1-23	136-139	for	_	_	
1-24	140-151	identifying	_	_	
1-25	152-160	specific	_	_	
1-26	161-171	pathogenic	_	_	
1-27	172-180	microbes	_	_	
1-28	181-184	and	_	_	
1-29	185-189	gene	_	_	
1-30	190-199	diagnosis	_	_	
1-31	200-203	for	_	_	
1-32	204-213	examining	_	_	
1-33	214-220	bodily	_	_	
1-34	221-234	constitutions	_	_	
1-35	235-237	of	_	_	
1-36	238-246	patients	_	_	
1-37	246-247	.	_	_	

#Text=However, as a matter of fact, the step of amplification of the nucleic acid, that of hybridization and that of detection of the target nucleic acid as listed above are conducted normally individually by means of respective apparatus and involve cumbersome operations to make the diagnosis considerably time consuming.
2-1	248-255	However	_	_	
2-2	255-256	,	_	_	
2-3	257-259	as	_	_	
2-4	260-261	a	_	_	
2-5	262-268	matter	_	_	
2-6	269-271	of	_	_	
2-7	272-276	fact	_	_	
2-8	276-277	,	_	_	
2-9	278-281	the	_	_	
2-10	282-286	step	_	_	
2-11	287-289	of	_	_	
2-12	290-303	amplification	_	_	
2-13	304-306	of	_	_	
2-14	307-310	the	_	_	
2-15	311-318	nucleic	_	_	
2-16	319-323	acid	_	_	
2-17	323-324	,	_	_	
2-18	325-329	that	_	_	
2-19	330-332	of	_	_	
2-20	333-346	hybridization	_	_	
2-21	347-350	and	_	_	
2-22	351-355	that	_	_	
2-23	356-358	of	_	_	
2-24	359-368	detection	_	_	
2-25	369-371	of	_	_	
2-26	372-375	the	_	_	
2-27	376-382	target	_	_	
2-28	383-390	nucleic	_	_	
2-29	391-395	acid	_	_	
2-30	396-398	as	_	_	
2-31	399-405	listed	_	_	
2-32	406-411	above	_	_	
2-33	412-415	are	_	_	
2-34	416-425	conducted	_	_	
2-35	426-434	normally	_	_	
2-36	435-447	individually	_	_	
2-37	448-450	by	_	_	
2-38	451-456	means	_	_	
2-39	457-459	of	_	_	
2-40	460-470	respective	_	_	
2-41	471-480	apparatus	_	_	
2-42	481-484	and	_	_	
2-43	485-492	involve	_	_	
2-44	493-503	cumbersome	_	_	
2-45	504-514	operations	_	_	
2-46	515-517	to	_	_	
2-47	518-522	make	_	_	
2-48	523-526	the	_	_	
2-49	527-536	diagnosis	_	_	
2-50	537-549	considerably	_	_	
2-51	550-554	time	_	_	
2-52	555-564	consuming	_	_	
2-53	564-565	.	_	_	

#Text=Particularly, when the hybridization reaction is made to take place on a glass slide, the probe can become missing or contaminated when the operator touches the glass slide with a fingertip because the probe-immobilizing region is exposed.
3-1	566-578	Particularly	_	_	
3-2	578-579	,	_	_	
3-3	580-584	when	_	_	
3-4	585-588	the	_	_	
3-5	589-602	hybridization	_	_	
3-6	603-611	reaction	_	_	
3-7	612-614	is	_	_	
3-8	615-619	made	_	_	
3-9	620-622	to	_	_	
3-10	623-627	take	_	_	
3-11	628-633	place	_	_	
3-12	634-636	on	_	_	
3-13	637-638	a	_	_	
3-14	639-644	glass	_	_	
3-15	645-650	slide	_	_	
3-16	650-651	,	_	_	
3-17	652-655	the	_	_	
3-18	656-661	probe	_	_	
3-19	662-665	can	_	_	
3-20	666-672	become	_	_	
3-21	673-680	missing	_	_	
3-22	681-683	or	_	_	
3-23	684-696	contaminated	_	_	
3-24	697-701	when	_	_	
3-25	702-705	the	_	_	
3-26	706-714	operator	_	_	
3-27	715-722	touches	_	_	
3-28	723-726	the	_	_	
3-29	727-732	glass	_	_	
3-30	733-738	slide	_	_	
3-31	739-743	with	_	_	
3-32	744-745	a	_	_	
3-33	746-755	fingertip	_	_	
3-34	756-763	because	_	_	
3-35	764-767	the	_	_	
3-36	768-786	probe-immobilizing	_	_	
3-37	787-793	region	_	_	
3-38	794-796	is	_	_	
3-39	797-804	exposed	_	_	
3-40	804-805	.	_	_	

#Text=Therefore, the operator is required to handle the probe very carefully.
4-1	806-815	Therefore	_	_	
4-2	815-816	,	_	_	
4-3	817-820	the	_	_	
4-4	821-829	operator	_	_	
4-5	830-832	is	_	_	
4-6	833-841	required	_	_	
4-7	842-844	to	_	_	
4-8	845-851	handle	_	_	
4-9	852-855	the	_	_	
4-10	856-861	probe	_	_	
4-11	862-866	very	_	_	
4-12	867-876	carefully	_	_	
4-13	876-877	.	_	_	

#Text=To avoid these and other problems, there have been proposed several biochemical reaction cassettes having a structure adapted to arrange a DNA micro-array in a reaction chamber, make a hybridization reaction to take place in the reaction chamber and conduct the subsequent detection step also in the reaction chamber.
#Text=[0009] FIGS. 7 and 8 illustrate such a biochemical reaction cassette.
5-1	878-880	To	_	_	
5-2	881-886	avoid	_	_	
5-3	887-892	these	_	_	
5-4	893-896	and	_	_	
5-5	897-902	other	_	_	
5-6	903-911	problems	_	_	
5-7	911-912	,	_	_	
5-8	913-918	there	_	_	
5-9	919-923	have	_	_	
5-10	924-928	been	_	_	
5-11	929-937	proposed	_	_	
5-12	938-945	several	_	_	
5-13	946-957	biochemical	_	_	
5-14	958-966	reaction	_	_	
5-15	967-976	cassettes	_	_	
5-16	977-983	having	_	_	
5-17	984-985	a	_	_	
5-18	986-995	structure	_	_	
5-19	996-1003	adapted	_	_	
5-20	1004-1006	to	_	_	
5-21	1007-1014	arrange	_	_	
5-22	1015-1016	a	_	_	
5-23	1017-1020	DNA	_	_	
5-24	1021-1032	micro-array	_	_	
5-25	1033-1035	in	_	_	
5-26	1036-1037	a	_	_	
5-27	1038-1046	reaction	_	_	
5-28	1047-1054	chamber	_	_	
5-29	1054-1055	,	_	_	
5-30	1056-1060	make	_	_	
5-31	1061-1062	a	_	_	
5-32	1063-1076	hybridization	_	_	
5-33	1077-1085	reaction	_	_	
5-34	1086-1088	to	_	_	
5-35	1089-1093	take	_	_	
5-36	1094-1099	place	_	_	
5-37	1100-1102	in	_	_	
5-38	1103-1106	the	_	_	
5-39	1107-1115	reaction	_	_	
5-40	1116-1123	chamber	_	_	
5-41	1124-1127	and	_	_	
5-42	1128-1135	conduct	_	_	
5-43	1136-1139	the	_	_	
5-44	1140-1150	subsequent	_	_	
5-45	1151-1160	detection	_	_	
5-46	1161-1165	step	_	_	
5-47	1166-1170	also	_	_	
5-48	1171-1173	in	_	_	
5-49	1174-1177	the	_	_	
5-50	1178-1186	reaction	_	_	
5-51	1187-1194	chamber	_	_	
5-52	1194-1195	.	_	_	
5-53	1196-1197	[	_	_	
5-54	1197-1201	0009	_	_	
5-55	1201-1202	]	_	_	
5-56	1203-1207	FIGS	_	_	
5-57	1207-1208	.	_	_	
5-58	1209-1210	7	_	_	
5-59	1211-1214	and	_	_	
5-60	1215-1216	8	_	_	
5-61	1217-1227	illustrate	_	_	
5-62	1228-1232	such	_	_	
5-63	1233-1234	a	_	_	
5-64	1235-1246	biochemical	_	_	
5-65	1247-1255	reaction	_	_	
5-66	1256-1264	cassette	_	_	
5-67	1264-1265	.	_	_	

#Text=FIG. 8 is a cross sectional view of the biochemical reaction cassette of FIG. 7 taken along a plane parallel to the vertical direction that includes the injection port and the discharge port.
6-1	1266-1269	FIG	_	_	
6-2	1269-1270	.	_	_	
6-3	1271-1272	8	_	_	
6-4	1273-1275	is	_	_	
6-5	1276-1277	a	_	_	
6-6	1278-1283	cross	_	_	
6-7	1284-1293	sectional	_	_	
6-8	1294-1298	view	_	_	
6-9	1299-1301	of	_	_	
6-10	1302-1305	the	_	_	
6-11	1306-1317	biochemical	_	_	
6-12	1318-1326	reaction	_	_	
6-13	1327-1335	cassette	_	_	
6-14	1336-1338	of	_	_	
6-15	1339-1342	FIG	_	_	
6-16	1342-1343	.	_	_	
6-17	1344-1345	7	_	_	
6-18	1346-1351	taken	_	_	
6-19	1352-1357	along	_	_	
6-20	1358-1359	a	_	_	
6-21	1360-1365	plane	_	_	
6-22	1366-1374	parallel	_	_	
6-23	1375-1377	to	_	_	
6-24	1378-1381	the	_	_	
6-25	1382-1390	vertical	_	_	
6-26	1391-1400	direction	_	_	
6-27	1401-1405	that	_	_	
6-28	1406-1414	includes	_	_	
6-29	1415-1418	the	_	_	
6-30	1419-1428	injection	_	_	
6-31	1429-1433	port	_	_	
6-32	1434-1437	and	_	_	
6-33	1438-1441	the	_	_	
6-34	1442-1451	discharge	_	_	
6-35	1452-1456	port	_	_	
6-36	1456-1457	.	_	_	

#Text=Referring to FIGS. 7 and 8, the biochemical reaction cassette 51 comprises a housing 52 and a glass substrate 53 to which a DNA probe that is to specifically bind to a target nucleic acid is immobilized.
7-1	1458-1467	Referring	_	_	
7-2	1468-1470	to	_	_	
7-3	1471-1475	FIGS	_	_	
7-4	1475-1476	.	_	_	
7-5	1477-1478	7	_	_	
7-6	1479-1482	and	_	_	
7-7	1483-1484	8	_	_	
7-8	1484-1485	,	_	_	
7-9	1486-1489	the	_	_	
7-10	1490-1501	biochemical	_	_	
7-11	1502-1510	reaction	_	_	
7-12	1511-1519	cassette	_	_	
7-13	1520-1522	51	_	_	
7-14	1523-1532	comprises	_	_	
7-15	1533-1534	a	_	_	
7-16	1535-1542	housing	_	_	
7-17	1543-1545	52	_	_	
7-18	1546-1549	and	_	_	
7-19	1550-1551	a	_	_	
7-20	1552-1557	glass	_	_	
7-21	1558-1567	substrate	_	_	
7-22	1568-1570	53	_	_	
7-23	1571-1573	to	_	_	
7-24	1574-1579	which	_	_	
7-25	1580-1581	a	_	_	
7-26	1582-1585	DNA	_	_	
7-27	1586-1591	probe	_	_	
7-28	1592-1596	that	_	_	
7-29	1597-1599	is	_	_	
7-30	1600-1602	to	_	_	
7-31	1603-1615	specifically	_	_	
7-32	1616-1620	bind	_	_	
7-33	1621-1623	to	_	_	
7-34	1624-1625	a	_	_	
7-35	1626-1632	target	_	_	
7-36	1633-1640	nucleic	_	_	
7-37	1641-1645	acid	_	_	
7-38	1646-1648	is	_	_	
7-39	1649-1660	immobilized	_	_	
7-40	1660-1661	.	_	_	

#Text=The housing 52 is provided with a dent section (recess) and part of the recess forms a reaction chamber 54 having a bottom surface where the DNA probe is immobilized as the housing 52 and the glass substrate 53 are bonded to each other.
8-1	1662-1665	The	_	_	
8-2	1666-1673	housing	_	_	
8-3	1674-1676	52	_	_	
8-4	1677-1679	is	_	_	
8-5	1680-1688	provided	_	_	
8-6	1689-1693	with	_	_	
8-7	1694-1695	a	_	_	
8-8	1696-1700	dent	_	_	
8-9	1701-1708	section	_	_	
8-10	1709-1710	(	_	_	
8-11	1710-1716	recess	_	_	
8-12	1716-1717	)	_	_	
8-13	1718-1721	and	_	_	
8-14	1722-1726	part	_	_	
8-15	1727-1729	of	_	_	
8-16	1730-1733	the	_	_	
8-17	1734-1740	recess	_	_	
8-18	1741-1746	forms	_	_	
8-19	1747-1748	a	_	_	
8-20	1749-1757	reaction	_	_	
8-21	1758-1765	chamber	_	_	
8-22	1766-1768	54	_	_	
8-23	1769-1775	having	_	_	
8-24	1776-1777	a	_	_	
8-25	1778-1784	bottom	_	_	
8-26	1785-1792	surface	_	_	
8-27	1793-1798	where	_	_	
8-28	1799-1802	the	_	_	
8-29	1803-1806	DNA	_	_	
8-30	1807-1812	probe	_	_	
8-31	1813-1815	is	_	_	
8-32	1816-1827	immobilized	_	_	
8-33	1828-1830	as	_	_	
8-34	1831-1834	the	_	_	
8-35	1835-1842	housing	_	_	
8-36	1843-1845	52	_	_	
8-37	1846-1849	and	_	_	
8-38	1850-1853	the	_	_	
8-39	1854-1859	glass	_	_	
8-40	1860-1869	substrate	_	_	
8-41	1870-1872	53	_	_	
8-42	1873-1876	are	_	_	
8-43	1877-1883	bonded	_	_	
8-44	1884-1886	to	_	_	
8-45	1887-1891	each	_	_	
8-46	1892-1897	other	_	_	
8-47	1897-1898	.	_	_	

#Text=An injection flow channel 55 and a discharge flow channel 56 are connected to the reaction chamber 54 so that the liquid specimen to be analyzed and one or more than one reagents may be injected and discharged.
#Text=[0010] The reaction chamber 54 of the biochemical reaction cassette 51 as illustrated in FIGS. 7 and 8 has only a small volume of tens of several microliters and bubbles are apt to remain in the reaction chamber 54 after filling it with liquid due to its structure.
9-1	1899-1901	An	_	_	
9-2	1902-1911	injection	_	_	
9-3	1912-1916	flow	_	_	
9-4	1917-1924	channel	_	_	
9-5	1925-1927	55	_	_	
9-6	1928-1931	and	_	_	
9-7	1932-1933	a	_	_	
9-8	1934-1943	discharge	_	_	
9-9	1944-1948	flow	_	_	
9-10	1949-1956	channel	_	_	
9-11	1957-1959	56	_	_	
9-12	1960-1963	are	_	_	
9-13	1964-1973	connected	_	_	
9-14	1974-1976	to	_	_	
9-15	1977-1980	the	_	_	
9-16	1981-1989	reaction	_	_	
9-17	1990-1997	chamber	_	_	
9-18	1998-2000	54	_	_	
9-19	2001-2003	so	_	_	
9-20	2004-2008	that	_	_	
9-21	2009-2012	the	_	_	
9-22	2013-2019	liquid	_	_	
9-23	2020-2028	specimen	_	_	
9-24	2029-2031	to	_	_	
9-25	2032-2034	be	_	_	
9-26	2035-2043	analyzed	_	_	
9-27	2044-2047	and	_	_	
9-28	2048-2051	one	_	_	
9-29	2052-2054	or	_	_	
9-30	2055-2059	more	_	_	
9-31	2060-2064	than	_	_	
9-32	2065-2068	one	_	_	
9-33	2069-2077	reagents	_	_	
9-34	2078-2081	may	_	_	
9-35	2082-2084	be	_	_	
9-36	2085-2093	injected	_	_	
9-37	2094-2097	and	_	_	
9-38	2098-2108	discharged	_	_	
9-39	2108-2109	.	_	_	
9-40	2110-2111	[	_	_	
9-41	2111-2115	0010	_	_	
9-42	2115-2116	]	_	_	
9-43	2117-2120	The	_	_	
9-44	2121-2129	reaction	_	_	
9-45	2130-2137	chamber	_	_	
9-46	2138-2140	54	_	_	
9-47	2141-2143	of	_	_	
9-48	2144-2147	the	_	_	
9-49	2148-2159	biochemical	_	_	
9-50	2160-2168	reaction	_	_	
9-51	2169-2177	cassette	_	_	
9-52	2178-2180	51	_	_	
9-53	2181-2183	as	_	_	
9-54	2184-2195	illustrated	_	_	
9-55	2196-2198	in	_	_	
9-56	2199-2203	FIGS	_	_	
9-57	2203-2204	.	_	_	
9-58	2205-2206	7	_	_	
9-59	2207-2210	and	_	_	
9-60	2211-2212	8	_	_	
9-61	2213-2216	has	_	_	
9-62	2217-2221	only	_	_	
9-63	2222-2223	a	_	_	
9-64	2224-2229	small	_	_	
9-65	2230-2236	volume	_	_	
9-66	2237-2239	of	_	_	
9-67	2240-2244	tens	_	_	
9-68	2245-2247	of	_	_	
9-69	2248-2255	several	_	_	
9-70	2256-2267	microliters	_	_	
9-71	2268-2271	and	_	_	
9-72	2272-2279	bubbles	*[1]	12-3[2_1]	
9-73	2280-2283	are	*[1]	_	
9-74	2284-2287	apt	*[1]	_	
9-75	2288-2290	to	*[1]	_	
9-76	2291-2297	remain	*[1]	_	
9-77	2298-2300	in	*[1]	_	
9-78	2301-2304	the	*[1]	_	
9-79	2305-2313	reaction	*[1]	_	
9-80	2314-2321	chamber	*[1]	_	
9-81	2322-2324	54	*[1]	_	
9-82	2325-2330	after	_	_	
9-83	2331-2338	filling	_	_	
9-84	2339-2341	it	_	_	
9-85	2342-2346	with	_	_	
9-86	2347-2353	liquid	_	_	
9-87	2354-2357	due	_	_	
9-88	2358-2360	to	_	_	
9-89	2361-2364	its	_	_	
9-90	2365-2374	structure	_	_	
9-91	2374-2375	.	_	_	

#Text=The biochemical reaction can be blocked and the diagnosis can be adversely affected when bubbles remain in the region where the DNA probe is immobilized to the glass substrate 53.
10-1	2376-2379	The	_	_	
10-2	2380-2391	biochemical	_	_	
10-3	2392-2400	reaction	_	_	
10-4	2401-2404	can	_	_	
10-5	2405-2407	be	_	_	
10-6	2408-2415	blocked	_	_	
10-7	2416-2419	and	_	_	
10-8	2420-2423	the	_	_	
10-9	2424-2433	diagnosis	_	_	
10-10	2434-2437	can	_	_	
10-11	2438-2440	be	_	_	
10-12	2441-2450	adversely	_	_	
10-13	2451-2459	affected	_	_	
10-14	2460-2464	when	_	_	
10-15	2465-2472	bubbles	_	_	
10-16	2473-2479	remain	_	_	
10-17	2480-2482	in	_	_	
10-18	2483-2486	the	_	_	
10-19	2487-2493	region	_	_	
10-20	2494-2499	where	_	_	
10-21	2500-2503	the	_	_	
10-22	2504-2507	DNA	_	_	
10-23	2508-2513	probe	_	_	
10-24	2514-2516	is	_	_	
10-25	2517-2528	immobilized	_	_	
10-26	2529-2531	to	_	_	
10-27	2532-2535	the	_	_	
10-28	2536-2541	glass	_	_	
10-29	2542-2551	substrate	_	_	
10-30	2552-2554	53	_	_	
10-31	2554-2555	.	_	_	

#Text=The operation of precisely controlling the movement of liquid so that bubble may not remain in the reaction chamber 54 is a cumbersome one and additionally such bubbles can form an obstacle when the biochemical reaction cassette is applied to an automatic diagnostic apparatus.
11-1	2556-2559	The	_	_	
11-2	2560-2569	operation	_	_	
11-3	2570-2572	of	_	_	
11-4	2573-2582	precisely	_	_	
11-5	2583-2594	controlling	_	_	
11-6	2595-2598	the	_	_	
11-7	2599-2607	movement	_	_	
11-8	2608-2610	of	_	_	
11-9	2611-2617	liquid	_	_	
11-10	2618-2620	so	_	_	
11-11	2621-2625	that	_	_	
11-12	2626-2632	bubble	_	_	
11-13	2633-2636	may	_	_	
11-14	2637-2640	not	_	_	
11-15	2641-2647	remain	_	_	
11-16	2648-2650	in	_	_	
11-17	2651-2654	the	_	_	
11-18	2655-2663	reaction	_	_	
11-19	2664-2671	chamber	_	_	
11-20	2672-2674	54	_	_	
11-21	2675-2677	is	_	_	
11-22	2678-2679	a	_	_	
11-23	2680-2690	cumbersome	_	_	
11-24	2691-2694	one	_	_	
11-25	2695-2698	and	_	_	
11-26	2699-2711	additionally	_	_	
11-27	2712-2716	such	_	_	
11-28	2717-2724	bubbles	_	_	
11-29	2725-2728	can	_	_	
11-30	2729-2733	form	_	_	
11-31	2734-2736	an	_	_	
11-32	2737-2745	obstacle	_	_	
11-33	2746-2750	when	_	_	
11-34	2751-2754	the	_	_	
11-35	2755-2766	biochemical	_	_	
11-36	2767-2775	reaction	_	_	
11-37	2776-2784	cassette	_	_	
11-38	2785-2787	is	_	_	
11-39	2788-2795	applied	_	_	
11-40	2796-2798	to	_	_	
11-41	2799-2801	an	_	_	
11-42	2802-2811	automatic	_	_	
11-43	2812-2822	diagnostic	_	_	
11-44	2823-2832	apparatus	_	_	
11-45	2832-2833	.	_	_	

#Text=To avoid this problem, Japanese Patent Application Laid-Open No. 2003-302399 discloses an arrangement where the reaction chamber is provided on the upper or lower surface thereof with a hydrophobic region and a hydrophilic region.
12-1	2834-2836	To	_	_	
12-2	2837-2842	avoid	_	_	
12-3	2843-2847	this	*[2]	_	
12-4	2848-2855	problem	*[2]	_	
12-5	2855-2856	,	_	_	
12-6	2857-2865	Japanese	_	_	
12-7	2866-2872	Patent	_	_	
12-8	2873-2884	Application	_	_	
12-9	2885-2894	Laid-Open	_	_	
12-10	2895-2897	No	_	_	
12-11	2897-2898	.	_	_	
12-12	2899-2903	2003	_	_	
12-13	2903-2904	-	_	_	
12-14	2904-2910	302399	_	_	
12-15	2911-2920	discloses	_	_	
12-16	2921-2923	an	_	_	
12-17	2924-2935	arrangement	_	_	
12-18	2936-2941	where	_	_	
12-19	2942-2945	the	_	_	
12-20	2946-2954	reaction	_	_	
12-21	2955-2962	chamber	_	_	
12-22	2963-2965	is	_	_	
12-23	2966-2974	provided	_	_	
12-24	2975-2977	on	_	_	
12-25	2978-2981	the	_	_	
12-26	2982-2987	upper	_	_	
12-27	2988-2990	or	_	_	
12-28	2991-2996	lower	_	_	
12-29	2997-3004	surface	_	_	
12-30	3005-3012	thereof	_	_	
12-31	3013-3017	with	_	_	
12-32	3018-3019	a	_	_	
12-33	3020-3031	hydrophobic	_	_	
12-34	3032-3038	region	_	_	
12-35	3039-3042	and	_	_	
12-36	3043-3044	a	_	_	
12-37	3045-3056	hydrophilic	_	_	
12-38	3057-3063	region	_	_	
12-39	3063-3064	.	_	_	

#Text=Japanese Patent Application Laid-Open No. 2004-093558 discloses an arrangement for preventing bubbles from being produced by means of a flow channel formed by using a protruding member in an upper part of the reaction region.
13-1	3065-3073	Japanese	_	_	
13-2	3074-3080	Patent	_	_	
13-3	3081-3092	Application	_	_	
13-4	3093-3102	Laid-Open	_	_	
13-5	3103-3105	No	_	_	
13-6	3105-3106	.	_	_	
13-7	3107-3111	2004	_	_	
13-8	3111-3112	-	_	_	
13-9	3112-3118	093558	_	_	
13-10	3119-3128	discloses	_	_	
13-11	3129-3131	an	_	_	
13-12	3132-3143	arrangement	_	_	
13-13	3144-3147	for	_	_	
13-14	3148-3158	preventing	_	_	
13-15	3159-3166	bubbles	_	_	
13-16	3167-3171	from	_	_	
13-17	3172-3177	being	_	_	
13-18	3178-3186	produced	_	_	
13-19	3187-3189	by	_	_	
13-20	3190-3195	means	_	_	
13-21	3196-3198	of	_	_	
13-22	3199-3200	a	_	_	
13-23	3201-3205	flow	_	_	
13-24	3206-3213	channel	_	_	
13-25	3214-3220	formed	_	_	
13-26	3221-3223	by	_	_	
13-27	3224-3229	using	_	_	
13-28	3230-3231	a	_	_	
13-29	3232-3242	protruding	_	_	
13-30	3243-3249	member	_	_	
13-31	3250-3252	in	_	_	
13-32	3253-3255	an	_	_	
13-33	3256-3261	upper	_	_	
13-34	3262-3266	part	_	_	
13-35	3267-3269	of	_	_	
13-36	3270-3273	the	_	_	
13-37	3274-3282	reaction	_	_	
13-38	3283-3289	region	_	_	
13-39	3289-3290	.	_	_	

#Text=Japanese Patent Application Laid-Open No. 2002-243748 discloses an arrangement for forming a uniformly spreading flow of liquid by means of a butterfly structure or a cascade structure.
#Text=[0011] The arrangement of Japanese Patent Application Laid-Open No. 2003-302399 and that of Japanese Patent Application Laid-Open No. 2004-093558, however, cannot completely eliminate bubbles remaining at and near the outlet port.
14-1	3291-3299	Japanese	_	_	
14-2	3300-3306	Patent	_	_	
14-3	3307-3318	Application	_	_	
14-4	3319-3328	Laid-Open	_	_	
14-5	3329-3331	No	_	_	
14-6	3331-3332	.	_	_	
14-7	3333-3337	2002	_	_	
14-8	3337-3338	-	_	_	
14-9	3338-3344	243748	_	_	
14-10	3345-3354	discloses	_	_	
14-11	3355-3357	an	_	_	
14-12	3358-3369	arrangement	_	_	
14-13	3370-3373	for	_	_	
14-14	3374-3381	forming	_	_	
14-15	3382-3383	a	_	_	
14-16	3384-3393	uniformly	_	_	
14-17	3394-3403	spreading	_	_	
14-18	3404-3408	flow	_	_	
14-19	3409-3411	of	_	_	
14-20	3412-3418	liquid	_	_	
14-21	3419-3421	by	_	_	
14-22	3422-3427	means	_	_	
14-23	3428-3430	of	_	_	
14-24	3431-3432	a	_	_	
14-25	3433-3442	butterfly	_	_	
14-26	3443-3452	structure	_	_	
14-27	3453-3455	or	_	_	
14-28	3456-3457	a	_	_	
14-29	3458-3465	cascade	_	_	
14-30	3466-3475	structure	_	_	
14-31	3475-3476	.	_	_	
14-32	3477-3478	[	_	_	
14-33	3478-3482	0011	_	_	
14-34	3482-3483	]	_	_	
14-35	3484-3487	The	_	_	
14-36	3488-3499	arrangement	_	_	
14-37	3500-3502	of	_	_	
14-38	3503-3511	Japanese	_	_	
14-39	3512-3518	Patent	_	_	
14-40	3519-3530	Application	_	_	
14-41	3531-3540	Laid-Open	_	_	
14-42	3541-3543	No	_	_	
14-43	3543-3544	.	_	_	
14-44	3545-3549	2003	_	_	
14-45	3549-3550	-	_	_	
14-46	3550-3556	302399	_	_	
14-47	3557-3560	and	_	_	
14-48	3561-3565	that	_	_	
14-49	3566-3568	of	_	_	
14-50	3569-3577	Japanese	_	_	
14-51	3578-3584	Patent	_	_	
14-52	3585-3596	Application	_	_	
14-53	3597-3606	Laid-Open	_	_	
14-54	3607-3609	No	_	_	
14-55	3609-3610	.	_	_	
14-56	3611-3615	2004	_	_	
14-57	3615-3616	-	_	_	
14-58	3616-3622	093558	_	_	
14-59	3622-3623	,	_	_	
14-60	3624-3631	however	_	_	
14-61	3631-3632	,	_	_	
14-62	3633-3639	cannot	_	_	
14-63	3640-3650	completely	_	_	
14-64	3651-3660	eliminate	_	_	
14-65	3661-3668	bubbles	_	_	
14-66	3669-3678	remaining	_	_	
14-67	3679-3681	at	_	_	
14-68	3682-3685	and	_	_	
14-69	3686-3690	near	_	_	
14-70	3691-3694	the	_	_	
14-71	3695-3701	outlet	_	_	
14-72	3702-3706	port	_	_	
14-73	3706-3707	.	_	_	

#Text=Similarly, with the arrangement of Japanese Patent Application Laid-Open No. 2002-243748, bubbles may be left in an upper part of the reaction chamber because the outlet port is connected to an end of the chamber.
15-1	3708-3717	Similarly	_	_	
15-2	3717-3718	,	_	_	
15-3	3719-3723	with	_	_	
15-4	3724-3727	the	_	_	
15-5	3728-3739	arrangement	_	_	
15-6	3740-3742	of	_	_	
15-7	3743-3751	Japanese	_	_	
15-8	3752-3758	Patent	_	_	
15-9	3759-3770	Application	_	_	
15-10	3771-3780	Laid-Open	_	_	
15-11	3781-3783	No	_	_	
15-12	3783-3784	.	_	_	
15-13	3785-3789	2002	_	_	
15-14	3789-3790	-	_	_	
15-15	3790-3796	243748	_	_	
15-16	3796-3797	,	_	_	
15-17	3798-3805	bubbles	_	_	
15-18	3806-3809	may	_	_	
15-19	3810-3812	be	_	_	
15-20	3813-3817	left	_	_	
15-21	3818-3820	in	_	_	
15-22	3821-3823	an	_	_	
15-23	3824-3829	upper	_	_	
15-24	3830-3834	part	_	_	
15-25	3835-3837	of	_	_	
15-26	3838-3841	the	_	_	
15-27	3842-3850	reaction	_	_	
15-28	3851-3858	chamber	_	_	
15-29	3859-3866	because	_	_	
15-30	3867-3870	the	_	_	
15-31	3871-3877	outlet	_	_	
15-32	3878-3882	port	_	_	
15-33	3883-3885	is	_	_	
15-34	3886-3895	connected	_	_	
15-35	3896-3898	to	_	_	
15-36	3899-3901	an	_	_	
15-37	3902-3905	end	_	_	
15-38	3906-3908	of	_	_	
15-39	3909-3912	the	_	_	
15-40	3913-3920	chamber	_	_	
15-41	3920-3921	.	_	_	

#Text=When bubbles are left at and near the outlet port, they can grow in the hybridization step to cover the DNA probe-immobilizing region because of the temperature rise in that step.
16-1	3922-3926	When	_	_	
16-2	3927-3934	bubbles	_	_	
16-3	3935-3938	are	_	_	
16-4	3939-3943	left	_	_	
16-5	3944-3946	at	_	_	
16-6	3947-3950	and	_	_	
16-7	3951-3955	near	_	_	
16-8	3956-3959	the	_	_	
16-9	3960-3966	outlet	_	_	
16-10	3967-3971	port	_	_	
16-11	3971-3972	,	_	_	
16-12	3973-3977	they	_	_	
16-13	3978-3981	can	_	_	
16-14	3982-3986	grow	_	_	
16-15	3987-3989	in	_	_	
16-16	3990-3993	the	_	_	
16-17	3994-4007	hybridization	_	_	
16-18	4008-4012	step	_	_	
16-19	4013-4015	to	_	_	
16-20	4016-4021	cover	_	_	
16-21	4022-4025	the	_	_	
16-22	4026-4029	DNA	_	_	
16-23	4030-4048	probe-immobilizing	_	_	
16-24	4049-4055	region	_	_	
16-25	4056-4063	because	_	_	
16-26	4064-4066	of	_	_	
16-27	4067-4070	the	_	_	
16-28	4071-4082	temperature	_	_	
16-29	4083-4087	rise	_	_	
16-30	4088-4090	in	_	_	
16-31	4091-4095	that	_	_	
16-32	4096-4100	step	_	_	
16-33	4100-4101	.	_	_	

#Text=Then, the biochemical reaction can be blocked to adversely affect the diagnosis.
#Text=[0012] Additionally, the arrangements of Japanese Patent Application Laid-Open No. 2003-302399, Japanese Patent Application Laid-Open No. 2004-093558 and Japanese Patent Application Laid-Open No. 2002-243748 require the cassette to be surface-treated and involve a complex profile for the reaction chamber to consequently raise the cost of manufacturing the cassettes.
17-1	4102-4106	Then	_	_	
17-2	4106-4107	,	_	_	
17-3	4108-4111	the	_	_	
17-4	4112-4123	biochemical	_	_	
17-5	4124-4132	reaction	_	_	
17-6	4133-4136	can	_	_	
17-7	4137-4139	be	_	_	
17-8	4140-4147	blocked	_	_	
17-9	4148-4150	to	_	_	
17-10	4151-4160	adversely	_	_	
17-11	4161-4167	affect	_	_	
17-12	4168-4171	the	_	_	
17-13	4172-4181	diagnosis	_	_	
17-14	4181-4182	.	_	_	
17-15	4183-4184	[	_	_	
17-16	4184-4188	0012	_	_	
17-17	4188-4189	]	_	_	
17-18	4190-4202	Additionally	_	_	
17-19	4202-4203	,	_	_	
17-20	4204-4207	the	_	_	
17-21	4208-4220	arrangements	_	_	
17-22	4221-4223	of	_	_	
17-23	4224-4232	Japanese	_	_	
17-24	4233-4239	Patent	_	_	
17-25	4240-4251	Application	_	_	
17-26	4252-4261	Laid-Open	_	_	
17-27	4262-4264	No	_	_	
17-28	4264-4265	.	_	_	
17-29	4266-4270	2003	_	_	
17-30	4270-4271	-	_	_	
17-31	4271-4277	302399	_	_	
17-32	4277-4278	,	_	_	
17-33	4279-4287	Japanese	_	_	
17-34	4288-4294	Patent	_	_	
17-35	4295-4306	Application	_	_	
17-36	4307-4316	Laid-Open	_	_	
17-37	4317-4319	No	_	_	
17-38	4319-4320	.	_	_	
17-39	4321-4325	2004	_	_	
17-40	4325-4326	-	_	_	
17-41	4326-4332	093558	_	_	
17-42	4333-4336	and	_	_	
17-43	4337-4345	Japanese	_	_	
17-44	4346-4352	Patent	_	_	
17-45	4353-4364	Application	_	_	
17-46	4365-4374	Laid-Open	_	_	
17-47	4375-4377	No	_	_	
17-48	4377-4378	.	_	_	
17-49	4379-4383	2002	_	_	
17-50	4383-4384	-	_	_	
17-51	4384-4390	243748	_	_	
17-52	4391-4398	require	_	_	
17-53	4399-4402	the	_	_	
17-54	4403-4411	cassette	_	_	
17-55	4412-4414	to	_	_	
17-56	4415-4417	be	_	_	
17-57	4418-4433	surface-treated	_	_	
17-58	4434-4437	and	_	_	
17-59	4438-4445	involve	_	_	
17-60	4446-4447	a	_	_	
17-61	4448-4455	complex	_	_	
17-62	4456-4463	profile	_	_	
17-63	4464-4467	for	_	_	
17-64	4468-4471	the	_	_	
17-65	4472-4480	reaction	_	_	
17-66	4481-4488	chamber	_	_	
17-67	4489-4491	to	_	_	
17-68	4492-4504	consequently	_	_	
17-69	4505-4510	raise	_	_	
17-70	4511-4514	the	_	_	
17-71	4515-4519	cost	_	_	
17-72	4520-4522	of	_	_	
17-73	4523-4536	manufacturing	_	_	
17-74	4537-4540	the	_	_	
17-75	4541-4550	cassettes	_	_	
17-76	4550-4551	.	_	_	
